Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Gross Profit: 2013-2025

Historic Gross Profit for OptimizeRx (OPRX) over the last 13 years, with Q3 2025 value amounting to $17.5 million.

  • OptimizeRx's Gross Profit rose 3025.95% to $17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.5 million, marking a year-over-year increase of 2957.1%. This contributed to the annual value of $59.4 million for FY2024, which is 3841.03% up from last year.
  • OptimizeRx's Gross Profit amounted to $17.5 million in Q3 2025, which was up 3025.95% from $18.6 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Gross Profit ranged from a high of $22.0 million in Q4 2024 and a low of $6.1 million during Q1 2021
  • Moreover, its 5-year median value for Gross Profit was $11.7 million (2024), whereas its average is $11.9 million.
  • Its Gross Profit has fluctuated over the past 5 years, first tumbled by 1295.83% in 2023, then skyrocketed by 6418.67% in 2024.
  • OptimizeRx's Gross Profit (Quarter) stood at $12.4 million in 2021, then grew by 0.51% to $12.5 million in 2022, then soared by 43.25% to $17.8 million in 2023, then increased by 23.44% to $22.0 million in 2024, then fell by 20.46% to $17.5 million in 2025.
  • Its last three reported values are $17.5 million in Q3 2025, $18.6 million for Q2 2025, and $13.3 million during Q1 2025.